ATE146218T1 - Hemmung von padgem-vermittelter zellbindung - Google Patents

Hemmung von padgem-vermittelter zellbindung

Info

Publication number
ATE146218T1
ATE146218T1 AT90917479T AT90917479T ATE146218T1 AT E146218 T1 ATE146218 T1 AT E146218T1 AT 90917479 T AT90917479 T AT 90917479T AT 90917479 T AT90917479 T AT 90917479T AT E146218 T1 ATE146218 T1 AT E146218T1
Authority
AT
Austria
Prior art keywords
padgem
inhibition
cell binding
mediated cell
cell
Prior art date
Application number
AT90917479T
Other languages
English (en)
Inventor
Bruce Furie
Eric Larsen
Alessandro Celi
Gary E Gilbert
Barbara C Furie
John K Erban
Roberta Bonfanti
Denisa D Wagner
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Application granted granted Critical
Publication of ATE146218T1 publication Critical patent/ATE146218T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Networks Using Active Elements (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90917479T 1989-10-20 1990-10-22 Hemmung von padgem-vermittelter zellbindung ATE146218T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42488689A 1989-10-20 1989-10-20

Publications (1)

Publication Number Publication Date
ATE146218T1 true ATE146218T1 (de) 1996-12-15

Family

ID=23684279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90917479T ATE146218T1 (de) 1989-10-20 1990-10-22 Hemmung von padgem-vermittelter zellbindung

Country Status (9)

Country Link
EP (1) EP0496832B1 (de)
JP (1) JPH05504470A (de)
AT (1) ATE146218T1 (de)
CA (1) CA2067250C (de)
DE (1) DE69029398T2 (de)
DK (1) DK0496832T3 (de)
ES (1) ES2097765T3 (de)
GR (1) GR3022011T3 (de)
WO (1) WO1991006632A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800815A (en) * 1903-05-05 1998-09-01 Cytel Corporation Antibodies to P-selectin and their uses
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5753631A (en) * 1990-06-15 1998-05-19 Cytel Corporation Intercellular adhesion mediators
DK0714912T3 (da) * 1990-07-17 2003-02-03 Univ Oklahoma Funktionelt aktive selektin-deriverede peptider og ligander for GMP-140
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US6309639B1 (en) 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US5807745A (en) * 1991-03-11 1998-09-15 New England Medical Center Hospitals, Inc. Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component
CA2105997A1 (en) * 1991-03-11 1992-09-12 Bruce Furie Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
CA2110495A1 (en) * 1991-06-10 1992-12-23 Robert M. Ippolito Immunosuppressive and tolerogenic oligosaccharide derivatives
US5646123A (en) * 1991-06-10 1997-07-08 Alberta Research Council Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
JPH07507040A (ja) 1991-09-10 1995-08-03 セントコー，インコーポレイテッド セレクチンによって介在される炎症のペプチド阻害剤
WO1993006863A1 (en) * 1991-09-30 1993-04-15 Biogen, Inc. Inhibition of vascular narrowing using anti-padgem antibodies
CA2104099A1 (en) * 1991-12-18 1993-06-19 George A. Heavner Peptide inhibitors of inflammation mediated by selectins
US6033667A (en) * 1992-05-05 2000-03-07 Cytel Corporation Method for detecting the presence of P-selectin
ATE237353T1 (de) * 1992-05-05 2003-05-15 Aeres Biomedical Ltd Antikörper gegen p-selectin und ihre verwendung
US6756211B1 (en) * 1992-05-11 2004-06-29 Corvas International, Inc. Neutropohil inhibitors
AU677261B2 (en) * 1992-10-23 1997-04-17 Genetics Institute, Llc Novel P-selectin ligand protein
US6277975B1 (en) 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
EP0668907A1 (de) * 1992-11-16 1995-08-30 Board Of Regents Of The University Of Oklahoma Glycoproteinligand für p-selection und verfahren zur dessen verwendung
WO1994025067A1 (en) * 1993-05-04 1994-11-10 Cytel Corporation Antibodies to p-selectin and their uses
WO1995030001A2 (en) * 1994-04-28 1995-11-09 Genetics Institute, Inc. Novel p-selectin ligand protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88308A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor
DK0714912T3 (da) * 1990-07-17 2003-02-03 Univ Oklahoma Funktionelt aktive selektin-deriverede peptider og ligander for GMP-140

Also Published As

Publication number Publication date
EP0496832B1 (de) 1996-12-11
DK0496832T3 (da) 1996-12-30
ES2097765T3 (es) 1997-04-16
GR3022011T3 (en) 1997-03-31
DE69029398T2 (de) 1997-04-10
CA2067250C (en) 2008-06-17
WO1991006632A1 (en) 1991-05-16
EP0496832A1 (de) 1992-08-05
DE69029398D1 (de) 1997-01-23
CA2067250A1 (en) 1991-04-21
EP0496832A4 (en) 1993-02-17
JPH05504470A (ja) 1993-07-15

Similar Documents

Publication Publication Date Title
DE69029398D1 (de) Hemmung von padgem-vermittelter zellbindung
EP0571053A3 (de) Analyseverfahren und Vorrichtung für Biologische specimen.
FI875609A7 (fi) Testikantaja kehon nesteiden ainesosasten analyyttistä määritystä varten.
DE3787771D1 (de) Elektrochemische Analysenmethode.
DE59003021D1 (de) Gerät zur entnahme von bodenproben.
ES517080A0 (es) Procedimiento de inmunoanalisis para determinar una iodotironina en una muestra de analisis.
ATE16820T1 (de) Testelement zur bestimmung von glukose in hoher konzentration.
DE68914538D1 (de) Isolator für eine erregerwicklung.
ES511797A0 (es) "metodo para ensayar reacciones antigeno-anticuerpo".
DE68907519D1 (de) Biosensoren.
DE59109048D1 (de) Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben
NO890867D0 (no) Fluidum-proevetaker, saerlig for benyttelse i en oljebroenn.
NO864113D0 (no) Fremgangsmaate for immonoassay, samt analysesett for dens utfoerelse.
SE7906799L (sv) Biologiskt indikatorsystem
DE68915767D1 (de) Selbsttätige, chemishe mehrfachproben-mehrfachreagens-analysierungsanordnung.
BR8701435A (pt) Processo de deteccao de ligante em fluido;processo de determinacao da concentracao de ligante em fluido;e conjunto de materiais para a realizacao de ensaio de ligante em fluido
DE68914617D1 (de) Nachweisvorrichtung für Kathodenlumineszenzanalyse.
ES509142A0 (es) Procedimiento para determinar la presencia de una analito en una muestra sospechosa de contenerlo.
NO910202L (no) Fremgangsmaate for aa identifisere hydrokarbonfoerende lag iundergrunnsformasjoner.
DE3750084D1 (de) Anordnung für Einführung von Vorrissen in Keramikproben.
ATE114817T1 (de) Immunologisches nachweisverfahren für herbizide.
DE69023426D1 (de) Behälter für Flüssigkeitsproben.
DE3853560D1 (de) Analytisches Element zur Vollblutuntersuchung.
DE69007155D1 (de) Automatisierte Schnittentwicklungsanalyse von mehrfachen Proben.
PT77153A (de) Drehzapfenlager fuer tueren insbesondere fuer pendeltueren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time